scholarly journals Myogenic Regulatory Factor Expression Is Downregulated Following Formoterol Stimulation In Thyroid Hormone Depleted Skeletal Muscle

2020 ◽  
Vol 52 (7S) ◽  
pp. 910-910
Author(s):  
Ryan A. Gordon ◽  
Gena D. Guerin ◽  
Emily L. Zumbro ◽  
Chase M. White ◽  
Dreanna M. McAdams ◽  
...  
Development ◽  
1993 ◽  
Vol 117 (4) ◽  
pp. 1409-1420 ◽  
Author(s):  
R. Moore ◽  
F.S. Walsh

The spatiotemporal distribution of M-cadherin mRNA has been determined by in situ hybridization in the mouse embryo and in adult skeletal muscle following experimental regeneration and denervation. M-cadherin mRNA is highly tissue specific and is found only in developing skeletal muscle. In contrast, N-cadherin mRNA has a broader tissue distribution in the embryo, being found on both neural elements and skeletal and cardiac muscle. M-cadherin is expressed in the myotomes shortly after they form, along with the myogenic regulatory factor myogenin. M-cadherin is expressed in muscles derived from the myotomes and is detected in forelimb bud precursor cells at embryonic day 11.5. In the latter case M-cadherin expression appears co-ordinately with that of myogenin and cardiac alpha-actin. Shortly before birth, M-cadherin expression is down regulated. M-cadherin can, however, be re-expressed following experimental regeneration of skeletal muscle. Here M-cadherin is transiently expressed on regenerating myoblasts but not myotubes. Following muscle denervation no evidence was found for re-expression of M-cadherin under conditions where there was strong expression of the nicotinic acetylcholine receptor on myofibres. The highly specific tissue distribution and unique developmental profile distinguishes M-cadherin from other cadherins and suggests a role in cell surface events during early myogenesis.


Micron ◽  
2008 ◽  
Vol 39 (8) ◽  
pp. 1306-1311 ◽  
Author(s):  
Fernanda Losi Alves de Almeida ◽  
Robson Francisco Carvalho ◽  
Danillo Pinhal ◽  
Carlos Roberto Padovani ◽  
Cesar Martins ◽  
...  

animal ◽  
2016 ◽  
Vol 10 (7) ◽  
pp. 1200-1203 ◽  
Author(s):  
J.S. Raja ◽  
M.L. Hoffman ◽  
K.E. Govoni ◽  
S.A. Zinn ◽  
S.A. Reed

1993 ◽  
Vol 265 (1) ◽  
pp. E176-E178 ◽  
Author(s):  
C. A. Maltin ◽  
M. I. Delday ◽  
G. P. Campbell ◽  
J. E. Hesketh

The amelioration of denervation atrophy by the beta-adrenoceptor agonist clenbuterol has led to the suggestion that the drug mimics or stimulates production of neurotrophic factors. Neurotrophic factors have profound effects on muscle growth, but the precise mechanisms through which this influence is exerted are unknown. The expression of myoD and myogenin, proteins that in turn regulate the transcription of tissue-specific genes during skeletal muscle differentiation, is controlled by innervation. In muscle undergoing denervation-induced atrophy, myoD and myogenin mRNAs increase. However, this is only partially reversed by electrical activity, thus implicating neurotrophic factors in regulation of these genes. Here we demonstrate that clenbuterol represses myoD and myogenin expression and decreases the levels of acetylcholine receptors in denervated muscles. The data provide the first evidence that the action of clenbuterol is directed through the neural axis.


2009 ◽  
Vol 108 (4) ◽  
pp. 771-778 ◽  
Author(s):  
Micah J. Drummond ◽  
Robert K. Conlee ◽  
Gary W. Mack ◽  
Sterling Sudweeks ◽  
G. Bruce Schaalje ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document